CompanyGraph
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 3.65: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.28%
Annual Rate
CNY 0.05Paid annual
Payout Ratio
7.1%Sustainable
Last Ex-Dividend
Jun 26, 2026
The reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
7.00BCNY1.04B · vs all stocks (USD)
Trailing P/E
24.65xRevenue (TTM)
2.40BCNY357.96M · vs all stocks (USD)
Profit Margin
11.72%Beta
1.02xvs all stocks
52-Week Change
24.72%vs all stocks
Market Capitalization
7.00BCNY1.04B · vs all stocks (USD)
Enterprise Value
5.73BCNY854.96M · vs all stocks (USD)
Trailing P/E
24.65xPrice to Sales (TTM)
2.92xPrice to Book (MRQ)
1.51xEnterprise to Revenue
2.39xEnterprise to EBITDA
11.16xGross Margin
13.22%Profit Margin
11.72%Operating Margin
3.68%Return on Assets (TTM)
3.09%Return on Equity (TTM)
6.26%Revenue (TTM)
2.40BCNY357.96M · vs all stocks (USD)
Revenue per Share (TTM)
6.05CNYUpdated Sep 21, 2026Quarterly Revenue Growth
42.20%Gross Profit (TTM)
535.26MCNY79.87M · vs all stocks (USD)
EBITDA (TTM)
402.95MCNY60.13M · vs all stocks (USD)
Net Income (TTM)
281.10MCNY41.95M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
42.15%Operating Cash Flow (TTM)
24.07MCNY3.59M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
8.66MCNY1.29M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0500CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.28%vs all stocks
Payout Ratio
7.06%Minority Interest (Equity)
-728.22KCNYFY2025 · Dec 31, 2025Revenue
1.94BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.58BCNYFY2025 · Dec 31, 2025Gross Profit
364.15MCNYFY2025 · Dec 31, 2025Operating Income
178.41MCNY26.62M · vs all stocks (USD)
Pre-tax Income
145.72MCNYFY2025 · Dec 31, 2025Income Tax Expense
28.09MCNYFY2025 · Dec 31, 2025Net Income
117.63MCNYFY2025 · Dec 31, 2025EBIT
159.50MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
402.95MCNYFY2025 · Dec 31, 2025Research & Development
83.90MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
54.55MCNYFY2025 · Dec 31, 2025Other Operating Expenses
17.97MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.56MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
13.79MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2999CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2999CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
396.98MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
396.98MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
117.63MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
1.42MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-499.67MCNYFY2025 · Dec 31, 2025Free Cash Flow
-653.65MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
387.59MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
117.63MCNYFY2025 · Dec 31, 2025Other Non-cash Items
18.23MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-579.11MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-56.42MCNYFY2025 · Dec 31, 2025Capital Expenditures
-153.98MCNYFY2025 · Dec 31, 2025Purchase of Investments
-5.47BCNYFY2025 · Dec 31, 2025Sale of Investments
5.39BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-240.63MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
504.55MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-307.91MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-28.07MCNYFY2025 · Dec 31, 2025Other Financing Charges
62.78MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
231.35MCNYFY2025 · Dec 31, 2025Shares Outstanding
400.01MSharesUpdated Sep 21, 2026Float Shares
159.03MSharesUpdated Sep 21, 2026% Held by Insiders
62.13%vs all stocks
% Held by Institutions
2.59%vs all stocks
Total Cash (MRQ)
1.87BCNY279.03M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.71CNYUpdated Sep 21, 2026Total Debt (MRQ)
656.83MCNY98.01M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1427xCurrent Ratio (MRQ)
2.63xBook Value per Share (MRQ)
11.60CNYUpdated Sep 21, 2026Total Assets
6.16BCNY919.88M · vs all stocks (USD)
Total Current Assets
3.30BCNYFY2025 · Dec 31, 2025Total Liabilities
1.71BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.87BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
464.57MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.24BCNYFY2025 · Dec 31, 2025Cash
387.40MCNYFY2025 · Dec 31, 2025Cash Equivalents
85.35MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
472.74MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.13BCNYFY2025 · Dec 31, 2025Accounts Receivable
449.53MCNYFY2025 · Dec 31, 2025Inventory
319.01MCNYFY2025 · Dec 31, 2025Accounts Payable
798.99MCNYFY2025 · Dec 31, 2025Short-term Debt
156.61MCNYFY2025 · Dec 31, 2025Other Current Liabilities
168.03MCNYFY2025 · Dec 31, 2025Long-term Debt
374.76MCNYFY2025 · Dec 31, 2025Common Stock (Book)
400.01MCNYFY2025 · Dec 31, 2025Retained Earnings
1.72BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.46BCNY665.35M · vs all stocks (USD)
Treasury Stock
47.15MCNYFY2025 · Dec 31, 202552-Week Low
13.97CNYUpdated Sep 21, 202652-Week High
35.58CNYUpdated Sep 21, 202652-Week Change
24.72%vs all stocks
Beta
1.02xvs all stocks
50-Day MA
19.55CNYUpdated Sep 21, 2026200-Day MA
23.21CNYUpdated Sep 21, 2026Avg 10-Day Volume
5.08MSharesUpdated Sep 21, 2026Avg 30-Day Volume
7.45MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.7100CNYUpdated Sep 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.42Receivables vs revenue divergence: 3.58
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 41,946,047.603Operating Cash Flow (USD, TTM): 3,591,619.752
Financial Health
Altman Z-Score 3.65: safe zoneNotable
Altman Z-Score: 3.65
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Aidea Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MeiraGTx Holdings plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Star Lake Bioscience Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Alto Neuroscience Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Jiangsu Kanion Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zylox-Tonbridge Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Xiangyu Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
China Animal Husbandry Industry Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Inkon Life Tech Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule